Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | -7 | 7 | 4 | 49 | 9 |
| Operating Income | 7 | -7 | -4 | -49 | -9 |
| Other Income | 1 | 1 | 2 | 2 | 2 |
| Pre-tax Income | 8 | -6 | -2 | -47 | -7 |
| Net Income Continuous | 8 | -6 | -2 | -47 | -7 |
| Net Income | $8 | $-6 | $-2 | $-47 | $-7 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| EBITDA(a) | $7 | $-7 | $-4 | $-49 | $-9 |